- Home
- JMM vs ABVC Comparison
JMM vs ABVC Comparison
Compare JMM & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- ABVC
- Stock Information
- Founded
- JMM 1988
- ABVC 2015
- Country
- JMM United States
- ABVC United States
- Employees
- JMM N/A
- ABVC N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- JMM Finance
- ABVC Health Care
- Exchange
- JMM Nasdaq
- ABVC Nasdaq
- Market Cap
- JMM 59.8M
- ABVC 52.1M
- IPO Year
- JMM N/A
- ABVC N/A
- Fundamental
- Price
- JMM $6.43
- ABVC $2.85
- Analyst Decision
- JMM
- ABVC
- Analyst Count
- JMM 0
- ABVC 0
- Target Price
- JMM N/A
- ABVC N/A
- AVG Volume (30 Days)
- JMM 16.1K
- ABVC 106.1K
- Earning Date
- JMM 01-01-0001
- ABVC 11-13-2025
- Dividend Yield
- JMM 5.44%
- ABVC N/A
- EPS Growth
- JMM N/A
- ABVC N/A
- EPS
- JMM N/A
- ABVC N/A
- Revenue
- JMM N/A
- ABVC $391,242.00
- Revenue This Year
- JMM N/A
- ABVC $735.18
- Revenue Next Year
- JMM N/A
- ABVC N/A
- P/E Ratio
- JMM N/A
- ABVC N/A
- Revenue Growth
- JMM N/A
- ABVC 186.84
- 52 Week Low
- JMM $5.29
- ABVC $0.40
- 52 Week High
- JMM $6.10
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- JMM 58.73
- ABVC 49.62
- Support Level
- JMM $6.29
- ABVC $2.64
- Resistance Level
- JMM $6.52
- ABVC $3.14
- Average True Range (ATR)
- JMM 0.08
- ABVC 0.17
- MACD
- JMM 0.01
- ABVC -0.01
- Stochastic Oscillator
- JMM 62.00
- ABVC 42.50
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.